Olean-11,13(18)-dien-3b b,30-diol dihemiphthalate (3), which was derived from glycyrrhetinic acid (GA), has been reported to produce a potent of anti-inflammatory effect in in vivo assays. Using 3 as a lead compound, we attempted to synthesize some modified compounds which varied in the following; i) the position of a carboxyl group in the phthalate moiety, ii) the number of carboxyls attached to the benzoyl group, iii) conversion of benzene ring to another ring system, iv) the linkage form between the benzene ring and oleanene skeleton at position 3 and/or 30. These were screened for their inhibitory activity against interleukin-1b b (IL-1b b ) 
Glycyrrhizin (GL), a main saponin component of several Glycyrrhiza species (G. uralensis, G. glabra, and G. inflata)
has been reported to possess various pharmacological activities such as anti-inflammation, 1) inhibition of prostaglandin E 2 (PGE 2 ) production in rat macrophages, 2) antiallergic, 3) antiviral 4, 5) action, and interferon-g-induction. 6) In Japan, a glycyrrhizin preparation, Stronger-Neo Minophagen C (SNMC), has been used extensively for more than 30 years to treat chronic hepatitis.
Glycyrrhetinic acid (GA), the aglycon of GL, is also known to have wide pharmacological effects such as anti-inflammation, 7, 8) antitumor, 9) antihepatotoxic activity, 10) and inhibition of the growth of mouse melanoma. 11) In 1989, it was reported that GA strongly inhibits renal 11b-hydroxysteroid dehydrogenase (11b-HSD) in rat, 12) which has been regarded as a cause of pseudoaldosteronism occasionally induced by the administration of a GL preparation or Carbenoxolone.
We have synthesized various GA derivatives, such as deoxo-glycyrrhetol (1), 13) olean-11,13(18)-dien-3b,30-diol (2), 14) and their succinate or hemi-phthalate 14) forms ( Fig. 1 ), in order to enhance the anti-inflammatory activity and suppress the pseudoaldosteronism due to the inhibition of mineralcorticoid metabolism. During the course of this work, 3 was reported to show various anti-inflammatory activities such as the inhibition of increasing vascular permeability, 15) 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse ear edema, 16) arachidonic acid-induced or capsaicin-induced mouse ear edema, 17, 18) and carrageenin-induced rat paw edema. 19) It was suggested that one of the mechanisms by which 3 induces anti-inflammatory effects is the inhibition of cyclooxygenase or lipoxygenase activities at the inflammatory site. 20) Interestingly, it was found that 3 exhibited antiacetic acid-induced writhing activity 15) and an antiulcer activity, 21) in addition to the anti-inflammation. In addition, we have reported that 3 did not inhibit the activity of 11b-HSD-2, which causes an adverse effect of GA. 22) These facts suggest that 3 is promising as a lead compound for a new type of anti-inflammatory agent, showing anti-inflammatory action as well as anti-ulcer action, different from conventional nonsteroidal anti-inflammatory drugs (NSAIDs), which are mostly ulcerogenic.
Recently, confirmed that normal human dermal fibroblasts (NHDF) produce PGE 2 in response to IL-1b. 23) In fact, NHDF have been used to assess the effect of compounds such as Tranilast and Azelastine on PGE 2 production. 24, 25) However, it is unclear whether 3 and its derivatives have an effect on COX-2 dependent PGE 2 production.
In this paper, we synthesized various new compounds derived from 3 and examined the effect of these compounds on IL-1b-induced PGE 2 production in NHDF.
Chemistry
In regard to the modification of 3, we focused on the following parts of 3: i) the position of the carboxyl group in the phthalate moiety (4, 5) , ii) the number of carboxyls attached to the benzoyl group (6) (7) (8) , iii) conversion of the benzene ring to other ring systems (9) (10) (11) (12) (13) , and iv) the linkage form between the benzene ring and oleanene skeleton at position 3 and/or 30 (17, (23) (24) (25) (26) (27) (28) (29) (30) (31) .
As shown in Chart 1, 4 and 5 were obtained by the reaction of 2 with isophthaloyl dichloride or terephthaloyl dichloride in pyridine in 20% and 15% yield, respectively. Esterification of 2 with benzoyl chloride, 1,3,5-benzenetricarbonyl trichloride or pyromellitic dianhydride in pyridine afforded 6, 7 and 8 in 82%, 16% and 35% yield, respectively.
Compounds (9) (10) (11) (12) , the benzoic acid of which were replaced by another ring system, were obtained in 10-45% yield by esterification of 2 with corresponding acid anhydride in pyridine. Compound (13) was prepared from 2 in 12% yield by activation of 2,5-thiophenedicarboxylic acid with 2-chloro-1-methylpyridinium iodide. 26, 27) Furthermore, in order to synthesize 17, 23 and 24, which were altered linkage forms between the oleanene skeleton and benzoic acid, 16, 19 and 22 were prepared by the method of Sun et al. 28) (Charts 2-4). Namely, after deriving 14 (3,30-dioxo form, 50% yield) from 2 with pyridinium chlorochromate (PCC) in dichloromethane, it was reacted with hydroxylamine hydrochloride in pyridine to give dioxime (15) in 69% yield. Then, the reduction of 15 with sodium cyanoborohydride in the presence of titanium(III) chloride and ammonium acetate in methanol afforded a mixture of 3a,30-and 3b,30-diamino forms. Since it was difficult to purify the mixture using silica gel column chromatography, t-butoxycarbonylation was carried out by a general method, then the product was purified using silica gel column chromatography. Next, the fraction was subjected to de-t-butoxycarbonylation with trifluoroacetic acid (TFA) to give 3b,30-diamine (16) in 44% overall yield. Compound (19) was prepared by using a synthetic method of 16 from a 3-oxo form, which was obtained by selective acetylation of the C-30 hydroxy group in 2 with one equivalent of acetic anhydride, followed by oxidation with Jones reagent, as shown in Chart 3. Compound (22) was synthesized from 21, which was prepared from 20 29) and ethyl chlorocarbonate, followed by reduction with sodium borohydride 30) in THF (Chart 3). Condensation of 16, 19 and 22 with phthalic anhydride in pyridine afforded 17, 23 and 24 in 75%, 75% and 86% yield, respectively (Charts 2, 4). Furthermore, deacetylation of 23 and 24, followed by their esterification with phthalic anhydride in pyridine, gave rise to 27 and 28, respectively (Chart 4).
As shown in Chart 5, 29 was obtained in 46% yield by the condensation of C-30 acyl halide, which was derived from the halogenation of 20 with thionyl chloride in THF, and anthranilic acid. 31) Deacetylation of 29 gave 30 in 99% yield, and then 30 was esterified with phthalic anhydride in pyridine to give 31 in 67% yield.
Results and Discussion
All the newly synthesized compounds at a concentration of 1 mM were evaluated for their inhibitory activity on IL1b-induced PGE 2 production in NHDF, and the results are summarized in Table 1 . N-(2-Cyclohexyl-oxy-4-nitrophenyl)-methanesulfonamide (NS-398) (100 nM), a cyclooxygenase-2 (COX-2) inhibitor, completely inhibited PGE 2 production in response to IL-1b (data not shown), indicating that the IL1b-induced PGE 2 is formed by the COX-2 dependent pathway.
23) The lead compound (3) showed weak activity (52Ϯ4% inhibition at 10 mM), whereas the meta-(4) or para-(5) carboxylic compounds led to an increase in the activity compared to that of 3. However, the potency remained moderate (56Ϯ5% inhibition at 1 mM). Furthermore, elimination (6) or an increase (7, 8) of the carboxyl group in the benzoic acid moiety resulted in loss of the inhibitory activity. These results clearly showed that the number or the position of the carboxyl group significantly affected the inhibitory activity.
Compounds (9) (10) (11) (12) (13) , in which the benzene rings in the benzoyl group were replaced by another ring system, showed more potent activity than that of 3. However, the potencies were only moderate in 10-12 (31-45% inhibition). Conversion of the ester bond at position 3 and/or 30 to the amide bond in 17, 23-28 also failed to get the desired effects, while 28 showed higher potency (IC 50 2.0 mM). In comparison with 17 and 27, 28 was potentiated in its biological activity by structural modification of the linkage between the mother skeleton and the phthalic acid at positions 30 and/or 3.
Compounds (29) (30) (31) , bearing a different amide linkage compared with 17 and 23-28, exhibited the most potent activity among the newly synthesized compounds. Particularly, 30 showed the most potent activity in this series (IC 50 1.0 mM). In contrast with the relation of the activity of 26 and 28, the inhibitory activity of 31 (IC 50 4.3 mM), in which phthalic acid was introduced into position 3 of 30, was decreased compared with that of 30.
In this series of the synthetic compounds, the introduction of anthranilic acid into position 30 is one of the significant factors for the expression of the activity. Thus, 30 may serve as a useful lead compound in the search for more powerful anti-inflammatory agents.
Experimental
General Experimental Procedures Melting points were taken on a Yanaco micro melting point apparatus and are uncorrected. 
3-Oxo-olean-11,13(18)-dien-30-al (14)
To a solution of 2 (2.00 g, 4.55 mmol) in CH 2 Cl 2 (21 ml) was added PCC (2.96 g, 13.7 mmol). After being stireed overnight at room temperature, the mixture was diluted with Et 2 O and filtered through a Florisil column. The eluate was concentrated under a vacuum, then the residue was chromatographed on silica gel with hexane-AcOEt 11,13(18)-dien-3,30-dioxime (15) A solution of 14 (1.8 g,  4. 1 mmol) and hydroxylamine hydrochloride (2.0 g, 29 mmol) in pyridine (10 ml) was heated for 3 h at 50°C. After cooling to room temperature, the reaction mixture was diluted with CHCl 3 and washed with 10% HCl. The CHCl 3 layer was dried over anhydrous Na 2 SO 4 1H, m, H-2b), 2.24 (1H, d, H-19), 1.38, 1.15,  1.11, 1.10, 1.02, 1.02, 0.80 (3Hϫ7, each s, H-23, H-24, H-25, H-26 .661 mmol) in pyridine (10 ml) was added phthalic anhydride (900 mg, 6.08 mmol). After being stireed for 3 h at 80°C, the reaction mixture was diluted with CHCl 3 , then the CHCl 3 layer was washed with 10% HCl, dried over anhydrous Na 2 SO 4 , and concentrated. To the residue was added MeOH, then the precipitates were filtered off to give 17 (362 mg, 75% in yield); mp 212°C; 
Olean-

30-O-Acetyl-olean-11,13(18)-dien-3b b-ol (18)
To a solution of 2 (2.0 g, 4.5 mmol) in pyridine (10 ml) was added acetic anhydride (0.86 ml) at 0°C, then stirring was continued for 6 h. The reaction mixture was poured into ice water and extracted with CHCl 3 . The CHCl 3 layer was washed with water, 10% HCl and aqueous NaHCO 3 , dried over anhydrous Na 2 SO 4 , and concentrated. The residue was chromatographed on silica gel with hexane-AcOEt (20 : 1→10 : 1→5 : 1) to give 18 (1.2 g, 54% in yield); mp 185-186°C; 1 H-NMR (400 MHz, CDCl 3 ) d 6.34 (1H, dd, J 9,11 ϭ2.9 Hz, J 11,12 ϭ10.5 Hz, H-11), 5.55 (1H, d, H-12 Acetyl-olean-11,13(18)-dien-3b b-amine (19) To a solution of 18 (105 mg, 0.218 mmol) in THF (5 ml) was added dropwise Jones reagent (5 drops), and then the mixture was stirred at room temperature for 15 min. The reaction mixture was filtered, then the filtrate was poured into ice water and extracted with CHCl 3 . The CHCl 3 layer was washed with water, dried over anhydrous Na 2 SO 4 , and concentrated. The residue was chromatographed on silica gel with hexane-AcOEt (20 : 1→10 : 1) to give 30-O-acetyl-olean-11,13(18)-dien-3-one (86 mg, 81% in yield); 1 H-NMR (CDCl 3 ) d 6.38 (1H, dd, J 9,11 ϭ3.1 Hz, J 11,12 ϭ10.4 Hz, H-11), 5.54 (1H, d, H-12), 3.85, 3.82  (1Hϫ2, each d, J gem ϭ10.4 Hz, H-30), 2.08 (3H, s, Ac), 1.10, 1.08, 1.04,  1.01, 0.98, 0.81, 0.75, (3Hϫ7, each s, H-23, H-24, H-25, H-26, H-27, H-28 C-13,  C-18), 125.8, 125.3 (C-11, C-12), 74.3 (C-30) . A solution of 30-O-acetylolean-11,13(18)-dien-3-one (229 mg, 0.476 mmol) and hydroxylamine hydrochloride (87 mg, 1.25 mmol) in pyridine (2 ml) was heated for 3 h at 50°C. After being cooled to room temperature, the reaction mixture was diluted with CHCl 3 and washed with 10% HCl. The CHCl 3 layer was dried over anhydrous Na 2 SO 4 and evaporated. The residue was chromatographed on silica gel with hexane-AcOEt 8 mmol) in THF (20 ml) was added ethyl chlorocarbonate (2.3 ml) and triethylamine (3.3 ml) at Ϫ5°C. The reaction mixture was stirred for 2 h at Ϫ5°C and filtrated. To the filtrate was added sodium borohydride (1.0 g, 15.9 mmol) in water (3 ml), and the mixture was stirred for 30 min at Ϫ5°C. The reaction mixture was evaporated, then the residue was dissolved in CHCl 3 . The solution was washed with water, dried over anhydrous Na 2 SO 4 , and concentrated. To the residue was added MeOH, then the precipitates were filtrated off to give 21 (2.0 g, 85% in yield); mp 214-216°C; 50 (1H, s) 
30-O-
